Kaken Pharmaceutical to Invest $7 Million in Venture Capital Fund

Venture Capital

Kaken Pharmaceutical to Invest $7 Million in Venture Capital Fund

November 11, 2022 admin 0 Comments information, KAKEN PHARMACEUTICAL CO., LTD. stock exchange, news, press release, | 4521 | JP3207000005

MT Newswires 2022

All news about KAKEN PHARMACEUTICAL CO., LTD.

Sales 2023	71 500 M 504 M 504 M
Net income 2023	10 800 M 76,1 M 76,1 M
Net Debt 2023	– – –
P/E ratio 2023	13,0x
Yield 2023	3,99%

Capitalization	141 B 992 M 992 M
Capi. / Sales 2023	1,97x
Capi. / Sales 2024	2,02x
Nbr of Employees	1 164
Free-Float	68,7%

Chart KAKEN PHARMACEUTICAL CO., LTD.

Duration :

Period :

Kaken Pharmaceutical Co., Ltd. Technical Analysis Chart | MarketScreener

Technical analysis trends KAKEN PHARMACEUTICAL CO., LTD.

	Short Term	Mid-Term	Long Term
Trends	Bearish	Neutral	Neutral

Income Statement Evolution

Sell Buy
Mean consensus	UNDERPERFORM
Number of Analysts	1
Last Close Price	3 760,00 JPY
Average target price	3 200,00 JPY
Spread / Average Target	-14,9%

.

Leave a Reply Cancel reply